PCM
Prelude Capital Management Portfolio holdings
AUM
$1.02B
1-Year Return
30.93%
This Quarter Return
+7.12%
1 Year Return
+30.93%
3 Year Return
+112.01%
5 Year Return
+170.21%
10 Year Return
+650.33%
AUM
$1.3B
AUM Growth
+$106M
(+8.9%)
Cap. Flow
+$44.2M
Cap. Flow
% of AUM
3.4%
Top 10 Holdings %
Top 10 Hldgs %
9.15%
Holding
1,524
New
403
Increased
352
Reduced
335
Closed
355
Top Buys
| 1 |
Kellanova
K
|
+$7.31M |
| 2 |
Core Scientific
CORZ
|
+$6.7M |
| 3 |
QuidelOrtho
QDEL
|
+$5.7M |
| 4 |
ProShares Bitcoin Strategy ETF
BITO
|
+$5.57M |
| 5 |
Li Auto
LI
|
+$5.54M |
Top Sells
| 1 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
+$11.1M |
| 2 |
Trip.com Group
TCOM
|
+$8.77M |
| 3 |
Western Digital
WDC
|
+$8.61M |
| 4 |
Harmonic Inc
HLIT
|
+$8.42M |
| 5 |
NetEase
NTES
|
+$7.33M |
Sector Composition
| 1 | Technology | 19.04% |
| 2 | Consumer Discretionary | 12.2% |
| 3 | Healthcare | 12.07% |
| 4 | Industrials | 10.82% |
| 5 | Communication Services | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Chegg
CHGG
$169M
| $56.5K | ﹤0.01% |
31,900
-3,134
| -9% | -$5.55K |
|
1102
Zentalis Pharmaceuticals
ZNTL
$118M
| $56K | ﹤0.01% |
+15,210
| New | +$56K |
|
1103
PMV Pharmaceuticals
PMVP
$74.2M
| $55.3K | ﹤0.01% |
37,100
-97,600
| -72% | -$145K |
|
1104
Advantage Solutions
ADV
$580M
| $55K | ﹤0.01% |
16,028
-8,700
| -35% | -$29.8K |
|
1105
Caribou Biosciences
CRBU
$169M
| $54.9K | ﹤0.01% |
28,010
+1,600
| +6% | +$3.14K |
|
1106
Red Cat Holdings
RCAT
$885M
| $54K | ﹤0.01% |
+21,278
| New | +$54K |
|
1107
Gilat Satellite Networks
GILT
$605M
| $53.6K | ﹤0.01% |
+10,172
| New | +$53.6K |
|
1108
BioAtla
BCAB
$35.9M
| $53.5K | ﹤0.01% |
+30,410
| New | +$53.5K |
|
|
ACCD
1109
DELISTED
Accolade, Inc. Common Stock
ACCD
| $50.2K | ﹤0.01% |
+13,042
| New | +$50.2K |
|
1110
Southland Holdings
SLND
$227M
| $46.7K | ﹤0.01% |
+12,612
| New | +$46.7K |
|
1111
WM Technology
MAPS
$132M
| $46.3K | ﹤0.01% |
53,265
-28,712
| -35% | -$25K |
|
1112
Ventyx Biosciences
VTYX
$170M
| $45.8K | ﹤0.01% |
21,000
+8,900
| +74% | +$19.4K |
|
1113
OmniAb
OABI
$246M
| $45.1K | ﹤0.01% |
10,670
-6,655
| -38% | -$28.2K |
|
1114
Tilray
TLRY
$1.23B
| $42.1K | ﹤0.01% |
23,903
| – | – |
|
1115
MaxCyte
MXCT
$150M
| $41.6K | ﹤0.01% |
+10,700
| New | +$41.6K |
|
1116
Sutro Biopharma
STRO
$83.3M
| $40.4K | ﹤0.01% |
11,689
-18,300
| -61% | -$63.3K |
|
1117
Torrid Holdings
CURV
$164M
| $39.8K | ﹤0.01% |
+10,117
| New | +$39.8K |
|
|
BOLD
1118
Boundless Bio
BOLD
$25.7M
| $38.3K | ﹤0.01% |
+11,024
| New | +$38.3K |
|
|
WHWK
1119
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.4M
| $36.7K | ﹤0.01% |
17,797
-18,400
| -51% | -$37.9K |
|
1120
Harvard Bioscience
HBIO
$20.2M
| $35.3K | ﹤0.01% |
13,111
-7,117
| -35% | -$19.1K |
|
1121
Oramed Pharmaceuticals
ORMP
$94.3M
| $35.2K | ﹤0.01% |
+14,435
| New | +$35.2K |
|
1122
Purple Innovation
PRPL
$118M
| $34.5K | ﹤0.01% |
+34,903
| New | +$34.5K |
|
|
DNMR
1123
DELISTED
Danimer Scientific, Inc.
DNMR
| $32.5K | ﹤0.01% |
1,792
-2,670
| -60% | -$48.5K |
|
1124
Metagenomi
MGX
$69.8M
| $30.5K | ﹤0.01% |
+14,074
| New | +$30.5K |
|
|
HYPD
1125
Hyperion DeFi, Inc. Common Stock
HYPD
$36.9M
| $29.7K | ﹤0.01% |
+719
| New | +$29.7K |
|